The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults

Coming Soon.

Year: 2022

Reference: Aljumaah, M. R., Bhatia, U., Roach, J., Gunstad, J., & Azcarate Peril, M. A. (2022). The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults. Clinical nutrition (Edinburgh, Scotland), 41(11), 2565–2576. https://doi.org/10.1016/j.clnu.2022.09.012

Related Studies

Seeing the wood for the trees: A new way to view the human intestinal microbiome and its connection with non-communicable disease

This 2019 paper briefly reviewed the connection of the intestinal microbiome to the rise in non-communicable conditions related to atopic disease, obesity and mental health. Following their analysis, Jheeta & Smith (2019) suggested that components of the microbiome assess microbial antigens in food and pass this information back to the immune system via chemical messengers […]

Towards microbiome-informed dietary recommendations for promoting metabolic and mental health: Opinion papers of the MyNewGut project

This introductory paper published in 2018 by the European project MyNewGut briefly summarizes the past research on the role of dietary patterns and food components in metabolic and mental health, and on several microbiome-mediating mechanisms. The authors state that since diet is a key modifiable environmental factor that modulates the gut microbiota and its metabolic […]